NY A 10967

in committee

Enhances transparency in the prescription drug supply chain

New York · 2025-2026 Regular Session · lower

Description

Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.

Introduced: —
Status date: —
Latest action: 2026-04-14 — REFERRED TO HEALTH
Bill type: bill
Last updated: —

Committees

Not provided by source.

Action timeline

2026-04-14
REFERRED TO HEALTH
referral-committee

Versions

A10967Compare

Documents

application/pdf(no extracted text yet)
text/html(no extracted text yet)

Votes

Not provided by source.

Related bills

Companion bill: S 9985

Official source

https://legislation.nysenate.gov/api/3/bills/2025-2026/A10967?summary=&detail=

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 10967. See the API docs or the MCP server for AI assistants.

Known limitations

Sponsor party and chamber affiliation are not yet captured by this API.
Committee referrals are not yet captured.
Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.